EpiVax Oncology To Present Latest Research On The Importance Of Identifying And Removing\, Using Machine-Learning Based Advanced Computational Tools\, Inhibitory Neoantigens From Therapeutic Cancer Vaccines\, At AACR Annual Meeting 2019